Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Apply
TYRA-300
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step